Allergan Sales, LLC
Date updated: 2026-04-19
TOTAL PRODUCT APPROVED: 3
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 3 |
Product count3
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 1 | |
| 1 | |
| 1 |
Product count1
Product count1
Product count1
Rows per page:
1–3 of 3
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| RESTASIS 0.05% w/w OPHTHALMIC EMULSION | MAL20071648ARZ | NEW CHEMICAL ENTITY | ABBVIE SDN BHD | Allergan Sales, LLC | ABBVIE SDN BHD | PRODUCT APPROVED |
| ZYMAXID (gatifloxacin ophthalmic solution) 0.5% | MAL15045158ARZ | NEW CHEMICAL ENTITY | ABBVIE SDN BHD | Allergan Sales, LLC | ABBVIE SDN BHD | PRODUCT APPROVED |
| ALPHAGAN P Ophthalmic Solution 0.1% | MAL20096002ARZ | NEW CHEMICAL ENTITY | ABBVIE SDN BHD | Allergan Sales, LLC | ABBVIE SDN BHD | PRODUCT APPROVED |
RESTASIS 0.05% w/w OPHTHALMIC EMULSION
Product Reg. noMAL20071648ARZ
TypeNEW CHEMICAL ENTITY
Product HolderABBVIE SDN BHD
ManufacturerAllergan Sales, LLC
ImporterABBVIE SDN BHD
Registration StatusPRODUCT APPROVED
ZYMAXID (gatifloxacin ophthalmic solution) 0.5%
Product Reg. noMAL15045158ARZ
TypeNEW CHEMICAL ENTITY
Product HolderABBVIE SDN BHD
ManufacturerAllergan Sales, LLC
ImporterABBVIE SDN BHD
Registration StatusPRODUCT APPROVED
ALPHAGAN P Ophthalmic Solution 0.1%
Product Reg. noMAL20096002ARZ
TypeNEW CHEMICAL ENTITY
Product HolderABBVIE SDN BHD
ManufacturerAllergan Sales, LLC
ImporterABBVIE SDN BHD
Registration StatusPRODUCT APPROVED
Rows per page:
1–3 of 3